| Q1 Earnings Surprise Well in Cards: Healthcare ETFs to Buy 12:05pm / Zacks.com - Paid Partner Content | US Stocks Edge Higher on Monday Apr 16 / GuruFocus News - Paid Partner Content |
| What's in the Cards for Glaxo (GSK) This Earnings Season? Apr 20 / Zacks.com - Paid Partner Content | Bristol-Myers Reports Positive Data in NSCLC Trial on Opdivo Apr 16 / Zacks.com - Paid Partner Content |
| Pharma Stock Roundup: NVS, JNJ Q1 Sales & Earnings Top, MRK & BMY Active at AACR Apr 20 / Zacks.com - Paid Partner Content | Merck's Keytruda Reduces Death Risk in Melanoma Patients Apr 16 / Zacks.com - Paid Partner Content |
| Lilly (LLY) to Report Q1 Earnings: What's in the Cards? Apr 20 / Zacks.com - Paid Partner Content | Dow 30 Stock Roundup: P&G Hikes Dividend; Boeing, American Airlines Ink $12B Deal Apr 13 / Zacks.com - Paid Partner Content |
| J&J, Novartis' Q1 Earnings Impress: Will Others Follow Suit? Apr 20 / Zacks.com - Paid Partner Content | Pharma Stock Roundup: NVS to Buy AveXis, PFE & ABBV's Drugs Succeed in Phase III Apr 13 / Zacks.com - Paid Partner Content |
| Bristol-Myers' Opdivo Gets Priority Review for Lung Cancer Apr 19 / Zacks.com - Paid Partner Content | Is J&J's (JNJ) Pharma Segment Likely to Drive Q1 Earnings? Apr 13 / Zacks.com - Paid Partner Content |
| Gillespie Robinson & Grimm Inc Buys Goldman Sachs Group Inc, Anadarko Petroleum Corp,... Apr 19 / GuruFocus News - Paid Partner Content | Nektar Starts Phase I/II Combo for Advanced Solid Tumors Apr 12 / Zacks.com - Paid Partner Content |
| Procter & Gamble Down Despite Earnings Beat Apr 19 / GuruFocus News - Paid Partner Content | Pfizer's Kidney Cancer Drug Misses Endpoint in Phase III Apr 11 / Zacks.com - Paid Partner Content |
| Merck's Keytruda Betters Survival in Lung Cancer Combo Study Apr 17 / Zacks.com - Paid Partner Content | vTv Therapeutics Crashes on Alzheimer's Drug Study Failure Apr 10 / Zacks.com - Paid Partner Content |
| Bristol-Myers (BMY) Down as Merck NSCLC Study Fares Better Apr 17 / Zacks.com - Paid Partner Content | Merck's Keytruda Offers Survival Benefit in Lung Cancer Study Apr 10 / Zacks.com - Paid Partner Content |
| J&J (JNJ) Tops Q1 Earnings Estimates, Raises Sales Guidance Apr 17 / Zacks.com - Paid Partner Content | NewLink Shares Plunge After Incyte & Merck's Study Fails Apr 09 / Zacks.com - Paid Partner Content |
| Company News For Apr 17, 2018 Apr 17 / Zacks.com - Paid Partner Content | Top Analyst Reports for Microsoft, Merck & Union Pacific Apr 09 / Zacks.com - Paid Partner Content |
| US Market Indexes Close Higher on Monday Apr 16 / GuruFocus News - Paid Partner Content | Incyte's Epacadostat Fails in Melanoma Study, Shares Plunge Apr 09 / Zacks.com - Paid Partner Content |
| Stop the market! I want to get off! Volatility is back Apr 16 / CNNMoney.com | Trump isn't as pro-business as he claims Mar 30 / CNNMoney.com |
+1.39 / +2.36%